HNB
IRON icon

Huntington National Bank’s Disc Medicine IRON Stock Holding History

Huntington National Bank’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$878 Buy
+12
New +$825 ﹤0.01% 2571

Other funds holding IRON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Huntington National Bank's IRON Position: Q2 2026 in Review

Huntington National Bank opened a new position in Disc Medicine (IRON) in Q2 2026: 12 shares worth $878. The stake represents ﹤0.01% of the portfolio and ranks #2571 among its holdings.

125 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Huntington National Bank held 12 shares of Disc Medicine worth $878 as of Q2 2026.
  • Disc Medicine was a new Huntington National Bank position in Q2 2026.
  • Disc Medicine made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #2571 holding.
  • 125 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.